Pharmaceuticals in Singapore

MarketLine
39 Pages - MLINE12989
$350.00

Summary

Pharmaceuticals in Singapore industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The Singaporean pharmaceuticals market had total revenues of $1.0m in 2018, representing a compound annual growth rate (CAGR) of 4.9% between 2014 and 2018.
- The performance of the market is forecast to follow a similar pattern with an anticipated CAGR of 4.8% for the five-year period 2018-2023, which is expected to drive the market to a value of $1.3m by the end of 2023.
- Singapore remains unique relative to other markets in punching above its weight in terms of size and population.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Singapore
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Singapore
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Singapore pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Singapore pharmaceuticals market by value in 2018?
- What will be the size of the Singapore pharmaceuticals market in 2023?
- What factors are affecting the strength of competition in the Singapore pharmaceuticals market?
- How has the market performed over the last five years?
- How large is Singapore’s pharmaceuticals market in relation to its regional counterparts?

'

Table of Contents
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Aspen Pharmacare Holdings Ltd
GlaxoSmithKline Plc
Novartis AG
Pfizer Inc
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

List of Tables
Table 1: Singapore pharmaceuticals market value: $ billion, 2014-18
Table 2: Singapore pharmaceuticals market geography segmentation: $ billion, 2018
Table 3: Singapore pharmaceuticals market share: % share, by value, 2018
Table 4: Singapore pharmaceuticals market value forecast: $ billion, 2018-23
Table 5: Aspen Pharmacare Holdings Ltd: key facts
Table 6: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 7: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 8: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 9: GlaxoSmithKline Plc: key facts
Table 10: GlaxoSmithKline Plc: key financials ($)
Table 11: GlaxoSmithKline Plc: key financials (£)
Table 12: GlaxoSmithKline Plc: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: Pfizer Inc: key facts
Table 17: Pfizer Inc: key financials ($)
Table 18: Pfizer Inc: key financial ratios
Table 19: Singapore size of population (million), 2014-18
Table 20: Singapore gdp (constant 2005 prices, $ billion), 2014-18
Table 21: Singapore gdp (current prices, $ billion), 2014-18
Table 22: Singapore inflation, 2014-18
Table 23: Singapore consumer price index (absolute), 2014-18
Table 24: Singapore exchange rate, 2014-18

List of Figures
Figure 1: Singapore pharmaceuticals market value: $ billion, 2014-18
Figure 2: Singapore pharmaceuticals market geography segmentation: % share, by value, 2018
Figure 3: Singapore pharmaceuticals market share: % share, by value, 2018
Figure 4: Singapore pharmaceuticals market value forecast: $ billion, 2018-23
Figure 5: Forces driving competition in the pharmaceuticals market in Singapore, 2018
Figure 6: Drivers of buyer power in the pharmaceuticals market in Singapore, 2018
Figure 7: Drivers of supplier power in the pharmaceuticals market in Singapore, 2018
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Singapore, 2018
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Singapore, 2018
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Singapore, 2018
Figure 11: Aspen Pharmacare Holdings Ltd: revenues & profitability
Figure 12: Aspen Pharmacare Holdings Ltd: assets & liabilities
Figure 13: GlaxoSmithKline Plc: revenues & profitability
Figure 14: GlaxoSmithKline Plc: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: Pfizer Inc: revenues & profitability
Figure 18: Pfizer Inc: assets & liabilities

$350.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838